キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/02 | 1,064 | 1,118 | 1,060 | 1,067 | -6 | -0.6% | 340,200 |
| 2023/08/01 | 1,063 | 1,080 | 1,033 | 1,073 | +10 | +0.9% | 276,100 |
| 2023/07/31 | 1,011 | 1,068 | 1,011 | 1,063 | +64 | +6.4% | 448,400 |
| 2023/07/28 | 986 | 1,008 | 962 | 999 | -2 | -0.2% | 547,700 |
| 2023/07/27 | 1,033 | 1,034 | 993 | 1,001 | -49 | -4.7% | 587,900 |
| 2023/07/26 | 1,070 | 1,077 | 1,050 | 1,050 | -31 | -2.9% | 263,300 |
| 2023/07/25 | 1,080 | 1,088 | 1,057 | 1,081 | +4 | +0.4% | 301,200 |
| 2023/07/24 | 1,113 | 1,114 | 1,075 | 1,077 | -52 | -4.6% | 381,000 |
| 2023/07/21 | 1,130 | 1,136 | 1,111 | 1,129 | +13 | +1.2% | 278,900 |
| 2023/07/20 | 1,110 | 1,136 | 1,096 | 1,116 | -17 | -1.5% | 294,600 |
| 2023/07/19 | 1,151 | 1,153 | 1,102 | 1,133 | -27 | -2.3% | 395,600 |
| 2023/07/18 | 1,206 | 1,208 | 1,144 | 1,160 | -39 | -3.3% | 618,500 |
| 2023/07/14 | 1,135 | 1,203 | 1,133 | 1,199 | +65 | +5.7% | 614,000 |
| 2023/07/13 | 1,098 | 1,152 | 1,080 | 1,134 | +34 | +3.1% | 431,700 |
| 2023/07/12 | 1,100 | 1,128 | 1,094 | 1,100 | +14 | +1.3% | 353,900 |
| 2023/07/11 | 1,124 | 1,130 | 1,066 | 1,086 | -26 | -2.3% | 466,400 |
| 2023/07/10 | 1,052 | 1,147 | 1,045 | 1,112 | +45 | +4.2% | 583,600 |
| 2023/07/07 | 1,055 | 1,091 | 1,041 | 1,067 | -13 | -1.2% | 628,200 |
| 2023/07/06 | 1,125 | 1,132 | 1,071 | 1,080 | -60 | -5.3% | 780,100 |
| 2023/07/05 | 1,195 | 1,201 | 1,130 | 1,140 | -56 | -4.7% | 536,300 |
| 2023/07/04 | 1,218 | 1,228 | 1,192 | 1,196 | -40 | -3.2% | 390,500 |
| 2023/07/03 | 1,225 | 1,263 | 1,225 | 1,236 | +6 | +0.5% | 274,600 |
| 2023/06/30 | 1,229 | 1,237 | 1,212 | 1,230 | -8 | -0.6% | 230,500 |
| 2023/06/29 | 1,223 | 1,246 | 1,210 | 1,238 | +5 | +0.4% | 224,300 |
| 2023/06/28 | 1,261 | 1,274 | 1,231 | 1,233 | -27 | -2.1% | 279,900 |
| 2023/06/27 | 1,284 | 1,285 | 1,221 | 1,260 | -37 | -2.9% | 485,400 |
| 2023/06/26 | 1,339 | 1,343 | 1,292 | 1,297 | -49 | -3.6% | 393,200 |
| 2023/06/23 | 1,305 | 1,363 | 1,302 | 1,346 | +32 | +2.4% | 358,700 |
| 2023/06/22 | 1,331 | 1,342 | 1,314 | 1,314 | -26 | -1.9% | 319,500 |
| 2023/06/21 | 1,332 | 1,351 | 1,325 | 1,340 | -3 | -0.2% | 197,400 |
| 2023/06/20 | 1,342 | 1,348 | 1,320 | 1,343 | -5 | -0.4% | 317,300 |
| 2023/06/19 | 1,361 | 1,369 | 1,340 | 1,348 | -32 | -2.3% | 340,900 |
| 2023/06/16 | 1,381 | 1,401 | 1,367 | 1,380 | +1 | +0.1% | 267,400 |
| 2023/06/15 | 1,373 | 1,405 | 1,365 | 1,379 | -5 | -0.4% | 281,400 |
| 2023/06/14 | 1,430 | 1,430 | 1,384 | 1,384 | -50 | -3.5% | 356,600 |
| 2023/06/13 | 1,460 | 1,477 | 1,430 | 1,434 | -56 | -3.8% | 663,500 |
| 2023/06/12 | 1,377 | 1,656 | 1,350 | 1,490 | +112 | +8.1% | 1,979,300 |
| 2023/06/09 | 1,360 | 1,390 | 1,338 | 1,378 | +42 | +3.1% | 476,900 |
| 2023/06/08 | 1,393 | 1,394 | 1,330 | 1,336 | -56 | -4% | 485,500 |
| 2023/06/07 | 1,400 | 1,480 | 1,375 | 1,392 | +103 | +8% | 2,158,700 |
| 2023/06/06 | 1,339 | 1,346 | 1,281 | 1,289 | -50 | -3.7% | 399,200 |
| 2023/06/05 | 1,355 | 1,362 | 1,335 | 1,339 | -15 | -1.1% | 219,800 |
| 2023/06/02 | 1,351 | 1,355 | 1,333 | 1,354 | -4 | -0.3% | 220,000 |
| 2023/06/01 | 1,359 | 1,375 | 1,331 | 1,358 | +5 | +0.4% | 259,000 |
| 2023/05/31 | 1,396 | 1,398 | 1,352 | 1,353 | -43 | -3.1% | 231,500 |
| 2023/05/30 | 1,391 | 1,406 | 1,362 | 1,396 | +4 | +0.3% | 262,700 |
| 2023/05/29 | 1,353 | 1,427 | 1,336 | 1,392 | +40 | +3% | 471,100 |
| 2023/05/26 | 1,351 | 1,383 | 1,338 | 1,352 | -24 | -1.7% | 328,000 |
| 2023/05/25 | 1,382 | 1,398 | 1,340 | 1,376 | -24 | -1.7% | 557,200 |
| 2023/05/24 | 1,411 | 1,450 | 1,395 | 1,400 | -36 | -2.5% | 555,200 |
451～
500
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 93,200円 | - | - | 0.00% | - | 5.96倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| 扶桑薬 | 215,900円 | +1.6% | -12.7% | 4.17% | 8.02倍 | 0.56倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,800円 | - | - | 0.00% | - | 2.84倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| オンコリス | 66,400円 | +3771.0% | - | 0.00% | - | 6.01倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| ラクオリア | 62,800円 | +25.1% | - | 0.00% | - | 2.77倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
